Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
54 /100
HIGH RISK
Score updated Aug 28, 2026

LIXT — Lixte Biotechnology Holdings, Inc. Dilution Risk Tracker

Track LIXT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LIXT — Get alerts when the score changes →

As of August 28, 2026, Lixte Biotechnology Holdings, Inc. (LIXT) has a DilutionWatch DilutionScore of 54/100, rated HIGH dilution risk. Lixte Biotechnology Holdings, Inc. has a market capitalization of $77.39M, 16.10M shares outstanding, 14 institutional holders tracked. Stored dilution-related fields include 113.3K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 12%
🔄 Reverse Split model est. 15%
• 52-week low $0.64 has breached $1
💰 Capital Raise model 15%
• Under 12 months cash (9mo)
🔔 Track LIXT — Get forecast alerts →

Market Data

Market Cap$77.39M
Shares Outstanding16.10M
Float11.11M
Cash$3.41M
Debt$1.03M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 1.6% shares (2026Q1 vs prior)
14 institutional holders · 782.0K shares
#1 SCOTIA CAPITAL INC. 283.2K shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 99.0K shares
#3 RENAISSANCE TECHNOLOGIES LLC 93.0K shares
+ 11 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
xbrl XBRL CONVERTIBLE 2026-03-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual LIXT Dilution Snapshot

Lixte Biotechnology Holdings, Inc. (LIXT) has a DilutionScore of 54/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track LIXT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LIXT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LIXT
LIXT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.